Trinity Biotech plc (ADR) (NASDAQ:TRIB)
CAPS Rating:
The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.
The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.
Recs
Found this off of a modified GB screen (ROA > 25%, Earnings Yield >10%. Also, earnings quality looks good and projected growth is solid.